Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Spruce Street Capital LP
Form 13F · Q2 2026

Spruce Street Capital LP

CIK 2050194申报日 2026-08-1313F-HR 在 EDGAR 查看原始申报 ↗
$5.1亿
申报组合市值
30
持仓数量
3
Quarters on record
Top 50
持仓数量

Spruce Street Capital LP——持仓

共 30 个持仓中的前 30 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1KNSA Kiniksa Pharmaceuticals Intl918,070+20.6%$5871万11.5%
2RLAY Relay Therapeutics Inc3.0M+0.0%$5583万11.0%
3LBRX Lb Pharmaceuticals Inc1.4M+0.0%$4466万8.8%
4RLMD Relmada Therapeutics Inc6.4M+2.1%$4423万8.7%
5ANRO Alto Neuroscience Inc1.4M+2.1%$3571万7.0%
6DNTH Dianthus Therapeutics Inc354,816−4.9%$3459万6.8%
7ALKS Alkermes Plc543,876+71.0%$2850万5.6%
8SVRA Savara Inc3.5M+2.1%$2127万4.2%
9PCVX Vaxcyte Inc306,047+24.6%$1779万3.5%
10ELVN Enliven Therapeutics Inc329,006+0.0%$1670万3.3%
11ENTA Enanta Pharmaceuticals Inc1.1M+16.7%$1587万3.1%
12CATX Perspective Therapeutics Inc3.7M+40.6%$1260万2.5%
13IFRX Inflarx Nv5.4M—$1199万2.4%
14SRZN Surrozen Inc432,040+0.0%$1121万2.2%
15ALMS Alumis Inc392,574+0.0%$1105万2.2%
16IPSC Century Therapeutics Inc4.1M+0.0%$994万2.0%
17NERV Minerva Neurosciences Inc1.7M+0.0%$919万1.8%
18SABS Sab Biotherapeutics Inc2.2M+0.0%$857万1.7%
19ANTX An2 Therapeutics Inc1.7M+0.0%$804万1.6%
20ERAS Erasca Inc422,543+0.0%$774万1.5%
21IKT Inhibikase Therapeutics Inc3.6M+0.0%$727万1.4%
22RACC Research Alliance Corp Iii500,000—$535万1.0%
23HLXC Helix Acquisition Corp Iii500,000+0.0%$532万1.0%
24ZLAB Zai Lab Ltd279,110—$530万1.0%
25QUIT Achieve Life Science Inc736,637—$481万0.9%
26LXEO Lexeo Therapeutics Inc928,593+0.0%$432万0.8%
27ALEC Alector Inc2.1M+0.0%$422万0.8%
28LONA Leonabio Inc393,701+0.0%$362万0.7%
29CRVS Corvus Pharmaceuticals Inc231,585+0.0%$346万0.7%
30JATT Jatt Ii Acquisition Corp160,000—$182万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。